Partnering to advance digital therapeutics offerings
pharmaphorum
APRIL 25, 2022
Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Configuring a collaboration.
Let's personalize your content